Larazotide acetateProduct ingredient for Larazotide

Name
Larazotide acetate
Drug Entry
Larazotide

An octapeptide inhibitor of paracellular permeability whose structure is derived from a protein (zonula occludens toxin) secreted by Vibrio cholerae for treatment of Coeliac disease.

Accession Number
DBSALT002605
Structure
Synonyms
Glycylglycyl-L-valyl-L-leucyl-L-valyl-L-glutaminyl-L-prolylglycine acetate
External IDs
AT 1001 / AT-1001
UNII
FO8S2IW40N
CAS Number
881851-50-9
Weight
Average: 785.897
Monoisotopic: 785.428318376
Chemical Formula
C34H59N9O12
InChI Key
NYGCNONRVCGHAT-UFIKZEAMSA-N
InChI
InChI=1S/C32H55N9O10.C2H4O2/c1-16(2)12-20(38-30(49)26(17(3)4)39-24(44)14-35-23(43)13-33)28(47)40-27(18(5)6)31(50)37-19(9-10-22(34)42)32(51)41-11-7-8-21(41)29(48)36-15-25(45)46;1-2(3)4/h16-21,26-27H,7-15,33H2,1-6H3,(H2,34,42)(H,35,43)(H,36,48)(H,37,50)(H,38,49)(H,39,44)(H,40,47)(H,45,46);1H3,(H,3,4)/t19-,20-,21-,26-,27-;/m0./s1
IUPAC Name
2-{[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-methylbutanamido]-4-methylpentanamido]-3-methylbutanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}acetic acid; acetic acid
SMILES
CC(O)=O.CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O
ChemSpider
28528060
ChEMBL
CHEMBL2103815
Wikipedia
Larazotide
Predicted Properties
PropertyValueSource
Water Solubility0.218 mg/mLALOGPS
logP-2ALOGPS
logP-6.2Chemaxon
logS-3.5ALOGPS
pKa (Strongest Acidic)3.43Chemaxon
pKa (Strongest Basic)7.84Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count11Chemaxon
Hydrogen Donor Count9Chemaxon
Polar Surface Area301.32 Å2Chemaxon
Rotatable Bond Count21Chemaxon
Refractivity180.06 m3·mol-1Chemaxon
Polarizability75.33 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability0Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon